Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Novello

Showing results (811-820 of 1,095) with videos related to

Pageof 110
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 12, 2018
Speleothem record of geomagnetic South Atlantic Anomaly recurrenceRicardo I F Trindade, Plinio Jaqueto, Filipe Terra-Nova, et al.
Recenti Progressi in Medicina|June 15, 2021
[Mutational oncology of lung cancer: molecular markers, drugs, negotiation conditions and experiences in national reference centers.]Immacolata Esposito, Silvia Calabria, Carlo Piccinni, et al.
Investigational New Drugs|November 9, 2012
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with erlotinibGrace K Dy, Jeffrey R Infante, S Gail Eckhardt, et al.
Journal of Cancer Research and Clinical Oncology|June 7, 2014
Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational studyCesare Gridelli, Filippo de Marinis, Andrea Ardizzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2014
A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancerS Novello, B Besse, E Felip, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2014
Analysis of patient-reported outcomes from the LUME-Lung 1 trial: a randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancerSilvia Novello, Rolf Kaiser, Anders Mellemgaard, et al.
Therapeutic Advances in Medical Oncology|June 15, 2018
Precision diagnostics of Ewing's sarcoma by liquid biopsy: circulating <i>EWS-FLI1</i> fusion transcriptsMatteo Allegretti, Beatrice Casini, Chiara Mandoj, et al.
Journal of Clinical Medicine|August 14, 2025
Evaluation of Nailfold Capillaroscopy as a Novel Tool in the Assessment of Eosinophilic Granulomatosis with PolyangiitisGianluca Screm, Ilaria Gandin, Lucrezia Mondini, et al.
ESMO Open|January 18, 2022
Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancerJ Wolf, Å Helland, I-J Oh, et al.
Journal of Psychiatric Research|December 27, 2008
Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophreniaDaniel Martins-de-Souza, Wagner F Gattaz, Andrea Schmitt, et al.
Pageof 110

Showing results (811-820 of 1,095) with videos related to

Sort By:
Pageof 110
Proceedings of the National Academy of Sciences of the United States of America|December 12, 2018
Speleothem record of geomagnetic South Atlantic Anomaly recurrenceRicardo I F Trindade, Plinio Jaqueto, Filipe Terra-Nova, et al.
Recenti Progressi in Medicina|June 15, 2021
[Mutational oncology of lung cancer: molecular markers, drugs, negotiation conditions and experiences in national reference centers.]Immacolata Esposito, Silvia Calabria, Carlo Piccinni, et al.
Investigational New Drugs|November 9, 2012
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with erlotinibGrace K Dy, Jeffrey R Infante, S Gail Eckhardt, et al.
Journal of Cancer Research and Clinical Oncology|June 7, 2014
Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational studyCesare Gridelli, Filippo de Marinis, Andrea Ardizzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2014
A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancerS Novello, B Besse, E Felip, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2014
Analysis of patient-reported outcomes from the LUME-Lung 1 trial: a randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancerSilvia Novello, Rolf Kaiser, Anders Mellemgaard, et al.
Therapeutic Advances in Medical Oncology|June 15, 2018
Precision diagnostics of Ewing's sarcoma by liquid biopsy: circulating <i>EWS-FLI1</i> fusion transcriptsMatteo Allegretti, Beatrice Casini, Chiara Mandoj, et al.
Journal of Clinical Medicine|August 14, 2025
Evaluation of Nailfold Capillaroscopy as a Novel Tool in the Assessment of Eosinophilic Granulomatosis with PolyangiitisGianluca Screm, Ilaria Gandin, Lucrezia Mondini, et al.
ESMO Open|January 18, 2022
Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancerJ Wolf, Å Helland, I-J Oh, et al.
Journal of Psychiatric Research|December 27, 2008
Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophreniaDaniel Martins-de-Souza, Wagner F Gattaz, Andrea Schmitt, et al.
Pageof 110